Suven Life Sciences Share Price
378.40+0.05 (+0.01%)
+75.70% past 1 Year
Suven Life Sciences provides wide range of Drug Discovery and Development Support Services (DDDSS) to global Pharma and Biotech companies. Suven has state-of-art facilities with highly qualified & experienced team
Corporate filings & documents
Announcements
Please find enclosed the News release
1 day agoPlease find enclosed the News release
1 day agoReport of Scrutinizer
1 week agoReport of Scrutinizer
1 week agoOutcome of 37th Annual General Meeting
1 week agoOutcome of 37th Annual General Meeting
1 week agoMonitoring Agency Report for the quarter ended 30th June 2026
3 weeks agoMonitoring Agency Report for the quarter ended 30th June 2026
3 weeks agoNewspaper publication- un-audited finacial results
4 weeks agoNewspaper publication- un-audited finacial results
4 weeks agoUn-audited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2026
4 weeks agoUn-audited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2026
4 weeks agoUn-audited Financial results for the quarter ended 30th June 2026
4 weeks agoUn-audited Financial results for the quarter ended 30th June 2026
4 weeks agoNewspaper Adv. regarding Notice of 37th Annual General Meeting of the Company and E-voting information
1 month agoNewspaper Adv. regarding Notice of 37th Annual General Meeting of the Company and E-voting information
1 month agoSuven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve Un-Audited Financial Results of the Company (Standalone and Consolidated) for the quarter ended 30th June 2026 and related matters
1 month agoSuven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve Un-Audited Financial Results of the Company (Standalone and Consolidated) for the quarter ended 30th June 2026 and related matters
1 month agoLetter to Shareholders regarding Annual Report FY 2025-26
1 month agoLetter to Shareholders regarding Annual Report FY 2025-26
1 month agoBusiness Responsibility and Sustainability Report (BRSR) for FY 2025-26
1 month agoBusiness Responsibility and Sustainability Report (BRSR) for FY 2025-26
1 month agoNotice of the 37th Annual General Meeting (AGM) of the Company
1 month agoNotice of the 37th Annual General Meeting (AGM) of the Company
1 month agoAnnual Report 2025-26 and Notice of 37th Annual General Meeting (AGM) of the Company
1 month agoAnnual Report 2025-26 and Notice of 37th Annual General Meeting (AGM) of the Company
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jasti Property and Equity Holdings Pvt Ltd & PACs
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jasti Property and Equity Holdings Pvt Ltd & PACs
1 month agoSpecial window for Re-Lodgment of transfer requests of Physical shares
1 month agoSpecial window for Re-Lodgment of transfer requests of Physical shares
1 month agoInteraction with Investors and Analysts
1 month agoInteraction with Investors and Analysts
1 month agoPlease find enclosed News Release of our company
1 month agoPlease find enclosed News Release of our company
1 month agoCertificate under Reg 74 (5) of SEBI (DP) Regulations 2018
1 month agoCertificate under Reg 74 (5) of SEBI (DP) Regulations 2018
1 month agoRevised outcome of the meeting of Board of Directors - Incorporation of Wholly owned Subsidiary (WOS) in Singapore
1 month agoRevised outcome of the meeting of Board of Directors - Incorporation of Wholly owned Subsidiary (WOS) in Singapore
1 month agoIncorporation of Wholly owned Subsidiary (WOS) in Singapore
1 month agoIncorporation of Wholly owned Subsidiary (WOS) in Singapore
1 month agoRe-appointment of Dr. Vajja Sambasiva Rao effective from January 21 2027 for a second term of 5(five) years
1 month agoRe-appointment of Dr. Vajja Sambasiva Rao effective from January 21 2027 for a second term of 5(five) years
1 month agoAllotment of 18570133 Equity shares of the Company on preferntial basis upon conversion of 18570133 fully paid warrants
1 month agoAllotment of 18570133 Equity shares of the Company on preferntial basis upon conversion of 18570133 fully paid warrants
1 month agoOutcome of Board Meeting
1 month agoOutcome of Board Meeting
1 month agoClosure of Trading Window
2 months agoClosure of Trading Window
2 months agoAllotment of 2 71 970 Equity shares upon exercise of vested options under SLSL ESOP 2020 Scheme
2 months agoAllotment of 2 71 970 Equity shares upon exercise of vested options under SLSL ESOP 2020 Scheme
2 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2022-10-17
Rights
1:2;54.0 (Rights ratio;Offer price)
2019-02-14
Dividend
1.5
2018-02-06
Dividend
1.5
2017-02-08
Dividend
1.0
2016-03-14
Dividend
2.0
2015-07-23
Dividend
0.6
2014-07-24
Dividend
2.5
2013-08-01
Dividend
0.3
2012-09-17
Dividend
0.3
2011-08-01
Dividend
0.25
2010-07-19
Dividend
0.25
Company details
Registered office
8-2-334, S D E Serene Chambers 6th Floor, Road No 5, Avenue 7 Banjara Hills Hyderabad Telangana PIN: 500034 Tel No: 040- 23541142 /3315 / 23543311 Fax No: 040- 23541152 Email: [email protected] Internet: www.suven.com
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Venkateswarlu Jasti, Chairman & Managing Director
Venkateswarlu Jasti, Chairman & Managing Director
Seyed E Hasnain, Non Executive Independent Director
Santanu Mukherjee, Non Executive Independent Director
JAS Padmaja, Non Executive Independent Director
Vajja Sambasiva Rao, Non Executive Independent Director
Sangeetha Laxmi Kandari, Company Secretary & Compliance Officer
Sudha Rani Jasti, Whole Time Director
Details
BSE 530239
NSE SUVEN
ISIN INE495B01038